Early Phase 1 Type 1 Diabetes Trial, Recruiting NCT03228732 Sponsor: University of Maryland, Baltimore Condition: Type 1 Diabetes
Back to Type 1 Diabetes

Early Phase 1 Type 1 Diabetes Trial, Recruiting

NCT03228732
Recruiting Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have Type 1 diabetes and are between 18 and 50 years old (the trial is looking for 32 men and 32 women).
  • Your recent blood sugar control test (HbA1c) result is below 11.0%.
  • You have not been diagnosed with diabetes-related complications such as eye disease, nerve damage, or skin ulcers.
  • Your body mass index (a measure of body weight relative to height) is below 40.

Who may not be able to join:

  • You are currently pregnant.
  • You are not able to give your own free and informed consent to participate.
  • You are taking blood-thinning (anticoagulant) medications, have anemia, or have a known bleeding disorder.
  • You are currently taking any of the following types of medication: non-selective beta blockers, sleeping pills or sedatives, anti-seizure medications, Parkinson's disease medications, antipsychotics, antidepressants, mood stabilizers, stimulants, opioids, or hallucinogens.
  • You have had a recent serious illness, or have a past history of severe depression, mania, or psychotic illness.
  • You score higher than 50 on a standard depression assessment scale.
  • You are unwilling or unable to use an approved method of contraception during the trial.
  • Your screening tests or physical examination show results that are considered medically significant.
  • You have a history of severely uncontrolled high blood pressure (above 160/100), heart disease, or a stroke or similar event.
  • You have a significant heart condition (such as heart failure, irregular heartbeat, or other cardiac abnormalities), either from your medical history or from a heart stress test (required if you are 40 or older).
  • You currently have pneumonia.
  • You have liver failure or jaundice.
  • Your kidney filtering measure (creatinine) is above 1.6 mg/dl.
  • You are currently experiencing an acute stroke or neurological episode.
  • You have a fever above 38°C (100.4°F).
  • Your blood count (hematocrit) is below 32 on lab tests.
  • Your white blood cell count is below 3 or above 14 (thousand per microlitre) on lab tests.
  • Your liver function test results are more than twice the upper limit of the normal range on lab tests.
  • Your total bilirubin level is above 2 mg/dl on lab tests (confirm with trial site).
  • Your alkaline phosphatase level is above 150 U/L on lab tests (confirm with trial site).
  • You test positive for HIV, Hepatitis B, or Hepatitis C.
  • Your liver enzyme levels are more than twice the normal level on lab tests.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Principal Investigator: Stephen N Davis, MBBS, University of Maryland, Baltimore

Phone: 410-706-5623

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Early Phase 1
Registry
ClinicalTrials.gov
Start date
19 December 2017
Est. completion
15 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in the level of catecholamines in plasma

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov